| Product NDC: | 62337-415 |
| Proprietary Name: | Pyrantel Pamoate |
| Non Proprietary Name: | PinwormTreatment |
| Active Ingredient(s): | 50 mg/mL & nbsp; PinwormTreatment |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 62337-415 |
| Labeler Name: | Neogen Corporation dba Columbia Laboratories |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part357B |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20121017 |
| Package NDC: | 62337-415-32 |
| Package Description: | 946.4 mL in 1 BOTTLE, PLASTIC (62337-415-32) |
| NDC Code | 62337-415-32 |
| Proprietary Name | Pyrantel Pamoate |
| Package Description | 946.4 mL in 1 BOTTLE, PLASTIC (62337-415-32) |
| Product NDC | 62337-415 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | PinwormTreatment |
| Dosage Form Name | SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 20121017 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Neogen Corporation dba Columbia Laboratories |
| Substance Name | PYRANTEL PAMOATE |
| Strength Number | 50 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |